Anthropic expands into life sciences and drug discovery ahead of IPO
Original article in Korean앤트로픽, 코딩 다음은 신약 개발…IPO 앞두고 생명과학 투자 확대
- Outlet
- AI Times
- Published
- Importance
- 3/5
Summary
Anthropic identified life sciences and drug discovery as key growth drivers in its SEC filing for an initial public offering. The company is expanding from software coding and enterprise AI into pharmaceutical and biotech markets.